ESR1 and neoplasm: In accordance with this idea, metformin (a mitochondrial complex I inhibitor) has been previously shown to overcome tamoxifen-resistance in ER(+) cell culture models, which mimic the tumor microenvironment by the addition of stromal fibroblasts [9–11].